Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Beuschlein

Showing results (381-390 of 445) with videos related to

Pageof 45
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical CarcinomaSilviu Sbiera, Iuliu Sbiera, Carmen Ruggiero, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|October 8, 2020
Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT)Youichi Ohno, Mitsuhide Naruse, Felix Beuschlein, et al.
Endocrinology|July 20, 2019
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor CulturesMaria Fankhauser, Nicole Bechmann, Michael Lauseker, et al.
European Journal of Endocrinology|May 13, 2021
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paragangliomaMasanori Murakami, Na Sun, Christian Greunke, et al.
The Journal of Clinical Endocrinology and Metabolism|April 11, 2024
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary CulturesKatharina Wang, Laura Schober, Alessa Fischer, et al.
The Lancet. Digital Health|July 20, 2023
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohortChristina Pamporaki, Annika M A Berends, Angelos Filippatos, et al.
Endocrine|September 18, 2021
Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paragangliomaNikolaos G Bliziotis, Leo A J Kluijtmans, Sebastian Soto, et al.
The Journal of Clinical Endocrinology and Metabolism|January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resectionFelix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Pageof 45

Showing results (381-390 of 445) with videos related to

Sort By:
Pageof 45
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical CarcinomaSilviu Sbiera, Iuliu Sbiera, Carmen Ruggiero, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|October 8, 2020
Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT)Youichi Ohno, Mitsuhide Naruse, Felix Beuschlein, et al.
Endocrinology|July 20, 2019
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor CulturesMaria Fankhauser, Nicole Bechmann, Michael Lauseker, et al.
European Journal of Endocrinology|May 13, 2021
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paragangliomaMasanori Murakami, Na Sun, Christian Greunke, et al.
The Journal of Clinical Endocrinology and Metabolism|April 11, 2024
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary CulturesKatharina Wang, Laura Schober, Alessa Fischer, et al.
The Lancet. Digital Health|July 20, 2023
Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohortChristina Pamporaki, Annika M A Berends, Angelos Filippatos, et al.
Endocrine|September 18, 2021
Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paragangliomaNikolaos G Bliziotis, Leo A J Kluijtmans, Sebastian Soto, et al.
The Journal of Clinical Endocrinology and Metabolism|January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resectionFelix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Pageof 45